Description: The US and EU are each pursuing modernization of their regulatory frameworks. The purpose of this paper is to provide a discussion of the emerging developments, the historical contexts or drivers of each, and potential implications for insurers. The paper discusses some of the global, wider financial services, and insurance specific activities underway that are influencing solvency developments for life insurers. It provides an overview of the differences in the current US and EU regimes and the regulatory changes underway. The paper then identifies key valuation implications, the impact on pricing and product design, and risk management implications.

Description: Traditional Medicare [TM] has many coverage gaps and no out-of-pocket maximum. Most members must purchase a Medicare Supplement Plan and a Part D plan for pharmacy coverage. Over 50% of members have opted for a Medicare Advantage [MA] plan that replaces TM and the need to purchase a Supplement and (in most cases) a Part D plan. All this for less cost to the member, but at a greater overall cost to the federal government even though MA plans provide TM benefits for less than it costs the government. The attendee will learn why this occurs. However, given these facts, the focus of the session will be on the future of Medicare: namely, should the parameters regarding MA bids and payments be limited to what is paid for TM, or can we take the best administrative techniques of MA and TM to provide more robust benefits for all Medicare members at a cost no greater than the government is currently paying? Or is there an even better idea?

Description: Prescription drug markets are undergoing rapid change - significant policy changes implemented through the Inflation Reduction Act, Congressional interest in long-awaited 340b reform, and a growing direct-to-consumer market have already changed the landscape significantly. The ongoing effects of these changes will continue to evolve for many years. Hear from leading prescription drug actuaries and pharmacy policy experts on what these changes mean for prescription drug markets and US healthcare more broadly.

Description: How are regulation and innovation intertwined? How do we regulate AI/ML in the insurance industry? We will cover how regulators are striking the balance between protection of their constituents and supporting innovation. We will zoom into the case of Predictive Analytics and the regulatory attempt at avoiding undue discrimination. Let's discuss what this really means.

Description: This session will provide an update on regulatory changes and current hot topics in Bermuda. The speakers will update you on the most recent Bermuda regulatory reforms, including targeted enhancements to its regulatory capital framework, Own Risk and Insolvency Amendment (ORSA)/Commercial Insurer's Insolvency Self Assessment (CISSA) enhancements for climate risk assessment, and Bermuda corporate income tax changes to align with Global Minimum Tax.

Description: LEARN is an offering to regulators about reinsurance. This article summarizes a session held for Brazilian health regulators in the fall of 2022.

Description: Session 10C: Redesigning the U.S. Health Care System - You Vote

Description: Actuary Dave Dillon describes his role volunteering his time as a teacher in higher education, including the rewards and challenges that teaching offers. He discusses the importance of being attentive to his audience’s pre-existing knowledge and adapting his presentations accordingly. His work as a teacher typically encompasses three distinct domains: 1) acquainting young students with the actuarial profession, 2) educating non-actuaries about public policy issues related to health insurance (including the Affordable Care Act), and 3) instructing current actuaries on advanced methodologies and principles within the field. Recently he taught a health insurance course for actuarial science graduate students at Georgia State University and lectured at Boise State University’s master's program in Population & Health Systems Management. In every teaching and mentoring opportunity, actuaries can contribute to the expansion and prosperity of the profession and are encouraged to pursue these endeavors.

Description: Overview of the regulatory requirements around sustainability reporting in Europe.

Description: An attorney and a statistician will discuss the latest on GenAI, the AI regulation and litigation affecting the use of AI in insurance.